REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $13 | +18.2% | 126 | 0.0% | 0.00% | – |
Q1 2023 | $11 | +175.0% | 126 | +16.7% | 0.00% | – |
Q4 2022 | $4 | -99.9% | 108 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 108 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 108 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | +33.3% | 108 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | -72.7% | 108 | 0.0% | 0.00% | – |
Q3 2021 | $11,000 | +22.2% | 108 | +74.2% | 0.00% | – |
Q2 2021 | $9,000 | +50.0% | 62 | 0.0% | 0.00% | – |
Q1 2021 | $6,000 | -14.3% | 62 | +14.8% | 0.00% | – |
Q4 2020 | $7,000 | -56.2% | 54 | -66.2% | 0.00% | – |
Q3 2020 | $16,000 | -27.3% | 160 | +4.6% | 0.00% | – |
Q2 2020 | $22,000 | 0.0% | 153 | 0.0% | 0.00% | – |
Q1 2020 | $22,000 | -29.0% | 153 | 0.0% | 0.00% | – |
Q4 2019 | $31,000 | +158.3% | 153 | 0.0% | 0.00% | – |
Q3 2019 | $12,000 | -14.3% | 153 | 0.0% | 0.00% | – |
Q2 2019 | $14,000 | +7.7% | 153 | 0.0% | 0.00% | – |
Q1 2019 | $13,000 | +116.7% | 153 | +39.1% | 0.00% | – |
Q4 2018 | $6,000 | -33.3% | 110 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | +125.0% | 110 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | +100.0% | 110 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | -99.8% | 110 | -99.7% | 0.00% | -100.0% |
Q1 2017 | $829,000 | – | 36,611 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |